DermTech (DMTK) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free DMTK Stock Alerts $0.70 -0.01 (-1.40%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media DermTech Stock Price Performance5 Day Performance+2.84%1 Month Performance-45.16%3 Month Performance-59.89%6 Month Performance-51.25%Year-To-Date Performance-59.89%1 Year Performance-80.77% Receive DMTK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DermTech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy DMTK Stock Chart for Friday, March, 29, 2024 DMTK Chart by TradingView DermTech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$0.71$0.70-0.99%$0.73$0.67163,423 shs$24.30 million03/27/2024$0.65$0.71+9.08%$0.71$0.65432,842 shs$24.55 million03/26/2024$0.66$0.65-1.52%$0.67$0.63302,222 shs$22.50 million03/25/2024$0.68$0.66-3.31%$0.69$0.65178,559 shs$22.85 million03/22/2024$0.71$0.68-4.13%$0.70$0.66253,266 shs$23.63 million03/21/2024$0.69$0.71+3.04%$0.72$0.70169,508 shs$24.65 million Get the Latest News and Ratings for DMTK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DermTech and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$0.69$0.69+0.57%$0.71$0.67138,435 shs$23.92 million03/19/2024$0.66$0.69+3.73%$0.70$0.66148,550 shs$23.79 million03/18/2024$0.69$0.66-4.14%$0.71$0.66227,424 shs$22.93 million03/15/2024$0.68$0.69+1.77%$0.71$0.66175,633 shs$23.92 million03/14/2024$0.70$0.68-3.28%$0.74$0.66172,367 shs$23.51 million03/13/2024$0.67$0.70+4.78%$0.74$0.66293,668 shs$24.30 million03/12/2024$0.65$0.67+2.37%$0.67$0.63409,349 shs$23.20 million03/11/2024$0.67$0.65-2.21%$0.70$0.64297,781 shs$22.66 million03/08/2024$0.70$0.67-4.28%$0.73$0.64921,854 shs$23.17 million03/07/2024$0.78$0.70-9.92%$0.80$0.691.11 million shs$24.21 million03/06/2024$0.85$0.78-9.12%$0.86$0.77839,635 shs$26.87 million03/05/2024$0.88$0.85-2.94%$0.92$0.84367,819 shs$29.57 million03/04/2024$0.87$0.88+1.15%$0.94$0.83661,708 shs$30.47 million03/01/2024$1.28$0.87-32.03%$1.15$0.812.83 million shs$29.79 million02/29/2024$1.33$1.28-3.76%$1.39$1.22604,958 shs$43.83 million02/28/2024$1.36$1.33-2.21%$1.39$1.26280,422 shs$45.54 million02/27/2024$1.31$1.36+3.82%$1.39$1.30263,553 shs$46.57 million02/26/2024$1.27$1.31+3.15%$1.35$1.27187,586 shs$44.85 million02/23/2024$1.30$1.27-2.31%$1.33$1.24173,802 shs$43.49 million02/22/2024$1.30$1.30$1.35$1.28152,252 shs$44.51 million02/21/2024$1.25$1.30+4.00%$1.32$1.25226,588 shs$44.51 million02/20/2024$1.33$1.25-6.02%$1.33$1.23178,763 shs$42.80 million02/19/2024$1.33$1.33$1.36$1.2785,000 shs$45.54 million02/16/2024$1.34$1.33-0.75%$1.36$1.2784,673 shs$45.54 million02/15/2024$1.30$1.34+3.08%$1.40$1.29195,501 shs$45.88 million02/14/2024$1.23$1.30+5.69%$1.32$1.23110,789 shs$44.51 million02/13/2024$1.29$1.23-4.65%$1.28$1.21192,244 shs$42.12 million02/12/2024$1.25$1.29+3.20%$1.32$1.22228,827 shs$44.17 million02/09/2024$1.20$1.25+4.17%$1.26$1.20158,558 shs$42.80 million02/08/2024$1.25$1.20-4.00%$1.27$1.19203,137 shs$41.09 million02/07/2024$1.31$1.25-4.58%$1.36$1.20213,440 shs$42.80 million02/06/2024$1.26$1.31+3.97%$1.37$1.23118,471 shs$44.85 million02/05/2024$1.23$1.26+2.44%$1.27$1.20236,982 shs$43.14 million02/02/2024$1.23$1.23$1.24$1.20169,928 shs$42.12 million[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>02/01/2024$1.20$1.23+2.50%$1.25$1.19192,360 shs$42.12 million01/31/2024$1.25$1.20-4.00%$1.30$1.17248,083 shs$41.09 million01/30/2024$1.33$1.25-6.02%$1.32$1.24129,466 shs$42.80 million01/29/2024$1.29$1.33+3.10%$1.36$1.28191,428 shs$45.54 million01/26/2024$1.26$1.29+2.38%$1.32$1.25212,083 shs$44.17 million01/25/2024$1.26$1.26$1.30$1.21225,004 shs$43.15 million01/24/2024$1.31$1.26-3.82%$1.34$1.24298,651 shs$43.14 million01/23/2024$1.28$1.31+2.34%$1.34$1.28133,545 shs$44.85 million01/22/2024$1.26$1.28+1.59%$1.35$1.25186,571 shs$43.83 million01/19/2024$1.24$1.26+1.61%$1.31$1.23303,461 shs$43.14 million01/18/2024$1.23$1.24+0.81%$1.29$1.21585,657 shs$42.46 million01/17/2024$1.30$1.23-5.38%$1.30$1.19409,896 shs$42.12 million01/16/2024$1.42$1.30-8.45%$1.44$1.29399,828 shs$44.51 million01/15/2024$1.42$1.42$1.50$1.40257,900 shs$48.62 million01/12/2024$1.46$1.42-2.74%$1.50$1.40257,836 shs$48.62 million01/11/2024$1.53$1.46-4.58%$1.50$1.40323,837 shs$49.99 million01/10/2024$1.65$1.53-7.27%$1.64$1.51353,503 shs$52.39 million01/09/2024$1.60$1.65+3.12%$1.69$1.57310,696 shs$56.50 million01/08/2024$1.41$1.60+13.48%$1.73$1.511.20 million shs$54.78 million01/05/2024$1.50$1.41-6.00%$1.52$1.38433,166 shs$48.28 million01/04/2024$1.53$1.50-1.96%$1.55$1.46324,213 shs$51.36 million01/03/2024$1.66$1.53-7.83%$1.70$1.50447,360 shs$52.39 million01/02/2024$1.75$1.66-5.14%$1.78$1.62329,142 shs$56.84 million01/01/2024$1.75$1.75$1.88$1.70540,200 shs$59.92 million12/29/2023$1.77$1.75-1.13%$1.88$1.70536,145 shs$59.92 million12/28/2023$1.88$1.77-5.85%$1.87$1.67523,066 shs$60.61 million Related Companies: Exagen Stock Price Chart Centogene Stock Price Chart Psychemedics Stock Price Chart BioNexus Gene Lab Stock Price Chart Akumin Stock Price Chart OpGen Stock Price Chart Renalytix Stock Price Chart Enzo Biochem Stock Price Chart Personalis Stock Price Chart CytoMed Therapeutics Stock Price Chart Receive DMTK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DermTech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMTK) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DermTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.